Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights Feb 26, 2026 04:17PM
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights Nov 6, 2025 04:01PM
Tectonic Therapeutic reports positive phase 1b trial data for TX45 Oct 29, 2025 04:01PM
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF Oct 29, 2025 04:01PM
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights Aug 7, 2025 04:01PM


Mar 20, 2025 04:01PM Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Nov 7, 2024 04:01PM Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
Oct 22, 2024 04:01PM Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Sep 19, 2024 04:01PM Tectonic Therapeutic (TECX) Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for TX45
Sep 19, 2024 04:01PM Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
Aug 20, 2024 04:01PM Tectonic Therapeutic to Participate in September Investor Conferences
Aug 14, 2024 04:01PM Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
Jul 30, 2024 04:01PM Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
Jun 20, 2024 04:01PM Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million